Abivax logo

Abivax

1 follower

Abivax SA is a clinical-stage, publicly traded biotechnology company harnessing the immune system to develop novel treatments against inflammatory diseases, viral diseases and cancer.

Industries

Headquarters

Paris, France

Employees

11-50

Links


Org chart

Marc De Garidel
Chief Executive Officer
Collapse
Ida Hatoum
Chief People Officer and Chief Compliance Officer
Didier Scherrer
Chief Scientific Officer
Pierre Courteille
Chief Business Officer
Nadege Briancon-Eris
Executive Leadership Team Member & Senior Vice President, Global Head of Development Operations
Fabio Cataldi
EVP And Chief Medical Officer
David Zhang
Chief Strategy Officer
Hema Keshava
Senior Vice President Finance
Christine Cook
Executive Business Partner | Head Of Administration US

Board & advisors

Ian McGowan
Chairman of the Scientific Advisory Board
Kinam Hong
Director
Corinna Zur Bonsen-Thomas
Member Board Of Directors, Interim Chairman 08/2022 - 05/2023,
Troy Ignelzi
Member Board of Directors
June Lee
Board Member
Christian Bréchot
Scientific Advisor
Christoph Huber
Scientific Advisor
Jürgen Rockstroh
Scientific Advisor
Lawrence R. Stanberry
Scientific Advisor
Christian Trépo
Scientific Advisor
Luc Teyton
Scientific Advisor